Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...

Quest Diagnostics, the world’s leading provider of diagnostic information services, on Monday said demand for COVID-19 tests “continues to outpace” capacity. Demand for molecular testing is highest in ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Quest Diagnostics on Thursday raised its full-year profit forecast, after demand for routine diagnostic testing helped ​the company beat second-quarter estimates.

Oct 24 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab on Tuesday raised its full-year sales forecast after beating third-quarter expectations for revenue and profit, buoyed ...

Quest Health’s tests may provide a convenient and accessible way for someone to gain insight into their health without needing to visit a doctor. They may also be beneficial for those who require ...